Denatured collagen and extracellular matrix proteins — Drug Target
All drugs that target Denatured collagen and extracellular matrix proteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- DGD · MediWound Ltd · Enzymatic debridement agent · Wound Care / Burn Treatment
DGD is a recombinant protease that selectively debrides necrotic tissue by breaking down denatured collagen and proteins in burn wounds.